Cargando…

Disease Progression in Multiple Sclerosis: A Literature Review Exploring Patient Perspectives

PURPOSE: Multiple sclerosis (MS) prognosis is often uncertain. This literature review considers patients’ understanding of, and perspectives on, MS progression to better comprehend the unmet needs of people with MS (PwMS), in order to improve treatment adherence and quality of life (QoL). METHODS: L...

Descripción completa

Detalles Bibliográficos
Autores principales:	Celius, Elisabeth G, Thompson, Heidi, Pontaga, Maija, Langdon, Dawn, Laroni, Alice, Potra, Stanca, Bharadia, Trishna, Yeandle, David, Shanahan, Jane, van Galen, Pieter, Alexandri, Nektaria, Kesselring, Jürg
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7802794/ https://www.ncbi.nlm.nih.gov/pubmed/33447018 http://dx.doi.org/10.2147/PPA.S268829

Ejemplares similares

Caregiver Involvement in MS: Duty or Disruption?
por: Kesselring, Jürg, et al.
Publicado: (2021)

Summary of Research: Caregiver Involvement in MS: Duty or Disruption?
por: Kesselring, Jürg, et al.
Publicado: (2023)

Summary of Research: Collaboration Between Healthcare Professionals and People with Multiple Sclerosis to Develop Communication Tools to Improve the Standard of Multiple Sclerosis Care
por: Oreja-Guevara, Celia, et al.
Publicado: (2023)

Joint Healthcare Professional and Patient Development of Communication Tools to Improve the Standard of MS Care
por: Oreja-Guevara, Celia, et al.
Publicado: (2019)

Knowledge Is Power, but Is Ignorance Bliss? Optimising Conversations About Disease Progression in Multiple Sclerosis
por: Vermersch, Patrick, et al.
Publicado: (2019)

Patient Power Revolution in Multiple Sclerosis: Navigating the New Frontier
por: Yeandle, David, et al.
Publicado: (2018)

What Is the True Impact of Cognitive Impairment for People Living with Multiple Sclerosis? A Commentary of Symposium Discussions at the 2020 European Charcot Foundation
por: Morrow, Sarah A., et al.
Publicado: (2023)

Breastfeeding and treatment of multiple sclerosis
por: Celius, Elisabeth G
Publicado: (2020)

Improvements in quality of life over 2 years with cladribine tablets in people with relapsing multiple sclerosis: The CLARIFY-MS study
por: Brochet, Bruno, et al.
Publicado: (2023)

CD56bright Natural Killer Cells: A Possible Biomarker of Different Treatments in Multiple Sclerosis
por: Laroni, Alice, et al.
Publicado: (2020)

Résultats cliniques des patients atteints de la COVID-19 au cours des études de phase IV sur la cladribine comprimés dans le traitement de la sclérose en plaques
por: Karan, Radmila, et al.
Publicado: (2021)

Reduction in grey matter atrophy in patients with relapsing multiple sclerosis following treatment with cladribine tablets
por: Cortese, Rosa, et al.
Publicado: (2022)

High prevalence of fatigue in contemporary patients with multiple sclerosis
por: Broch, Line, et al.
Publicado: (2021)

The influence of THC:CBD oromucosal spray on driving ability in patients with multiple sclerosis‐related spasticity
por: Celius, Elisabeth G., et al.
Publicado: (2018)

Factors affecting adherence to disease-modifying therapies in multiple sclerosis: systematic review
por: Washington, Francesca, et al.
Publicado: (2021)

Analysis of frequency and severity of relapses in multiple sclerosis patients treated with cladribine tablets or placebo: The CLARITY and CLARITY Extension studies
por: De Stefano, Nicola, et al.
Publicado: (2021)

The diagnostic value of IgG index versus oligoclonal bands in cerebrospinal fluid of patients with multiple sclerosis
por: Simonsen, Cecilia Smith, et al.
Publicado: (2020)

A Systematic Review and Meta-Analysis of the Brief Cognitive Assessment for Multiple Sclerosis (BICAMS)
por: Corfield, Freya, et al.
Publicado: (2018)

State of the Art and Future Challenges in Multiple Sclerosis Research and Medical Management: An Insight into the 5th International Porto Congress of Multiple Sclerosis
por: Sá, María José, et al.
Publicado: (2020)

Antibody response to SARS-CoV-2 vaccines in patients with relapsing multiple sclerosis treated with evobrutinib: A Bruton’s tyrosine kinase inhibitor
por: Bar-Or, Amit, et al.
Publicado: (2023)

A Systematic Review and Meta-Analysis of the Brief Cognitive Assessment for Multiple Sclerosis (BICAMS) International Validations
por: Potticary, Hannah, et al.
Publicado: (2023)

The course of multiple sclerosis rewritten: a Norwegian population-based study on disease demographics and progression
por: Simonsen, Cecilia Smith, et al.
Publicado: (2020)

Regulatory Functions of Natural Killer Cells in Multiple Sclerosis
por: Gross, Catharina C., et al.
Publicado: (2016)

Rebaseline no evidence of disease activity (NEDA-3) as a predictor of long-term disease course in a Norwegian multiple sclerosis population
por: Simonsen, Cecilia Smith, et al.
Publicado: (2022)

The effect of self-assessed fatigue and subjective cognitive impairment on work capacity: The case of multiple sclerosis
por: Kobelt, Gisela, et al.
Publicado: (2018)

Early High Efficacy Treatment in Multiple Sclerosis Is the Best Predictor of Future Disease Activity Over 1 and 2 Years in a Norwegian Population-Based Registry
por: Simonsen, Cecilia Smith, et al.
Publicado: (2021)

Management of Severe Graves’ Hyperthyroidism in Pregnancy Following Immune Reconstitution Therapy in Multiple Sclerosis
por: Hammerstad, Sara Salehi, et al.
Publicado: (2021)

Open Mental Health: A Mental Health Eco System Developed in Collaboration With Communities
por: Yeandle, Jane, et al.
Publicado: (2022)

Vaccinations in patients with multiple sclerosis: a real-world, single-center experience
por: Sbragia, Elvira, et al.
Publicado: (2022)

Shoulder Rotator Muscle Dynamometry Characteristics: Side Asymmetry and Correlations with Ball-Throwing Speed in Adolescent Handball Players
por: Pontaga, Inese, et al.
Publicado: (2014)

Immune Soluble Factors in the Cerebrospinal Fluid of Progressive Multiple Sclerosis Patients Segregate Into Two Groups
por: Donninelli, Gloria, et al.
Publicado: (2021)

From Provider to Enabler of Care? Reconfiguring Local Authority Support for Older People and Carers in Leeds, 2008 to 2013
por: Yeandle, Sue
Publicado: (2016)

Multiple sclerosis and primary vascular dysregulation (Flammer syndrome)
por: Konieczka, Katarzyna, et al.
Publicado: (2016)

Normal antibody response after COVID-19 during treatment with cladribine
por: Celius, Elisabeth G.
Publicado: (2020)

Validation of the brief international cognitive assessment for multiple sclerosis (BICAMS) in the Portuguese population with multiple sclerosis
por: Sousa, Cláudia, et al.
Publicado: (2018)

Effects of Mobility-Enhancing Nursing Intervention in Patients with MS and Stroke: Randomised Controlled Trial
por: Imhof, Lorenz, et al.
Publicado: (2015)

Safety of the first dose of fingolimod for multiple sclerosis: results of an open-label clinical trial
por: Laroni, Alice, et al.
Publicado: (2014)

Month of birth and risk of multiple sclerosis: confounding and adjustments
por: Torkildsen, Øivind, et al.
Publicado: (2014)

Predictors of Ocrelizumab Effectiveness in Patients with Multiple Sclerosis
por: Cellerino, Maria, et al.
Publicado: (2021)

Bone Turnover and Metabolism in Patients with Early Multiple Sclerosis and Prevalent Bone Mass Deficit: A Population-Based Case-Control Study
por: Moen, Stine Marit, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_smh6ejac695o0tgd7pp1580at1